PAG, a leading global investment firm, announced that its private equity strategy, along with consortium partners CX Partners and Samara Capital, has completed the acquisition of a controlling stake in the Optimus Group, a Hyderabad, India-based pharmaceutical firm, through the API platform, Sekhmet Pharmaventures.
Founded in 2004, Optimus is a vertically integrated manufacturer of pharmaceutical products including advanced intermediates, active pharmaceutical ingredients (APIs) and finished drugs. It currently exports more than 100 products to 40 countries.
Nikhil Srivastava, partner and managing director, head of India Private Equity for PAG, commented:
